Bristol-Myers Squibb Company (BMY): A Bull Case Theory
We came across a bullish thesis on Bristol-Myers Squibb Company (BMY) on Disruptive analytics’ Substack by Magnus Ofstad. In ...
Bristol Myers says Opdivo + Yervoy cut risk of relapse by 38% in colorectal cancer
Bristol Myers Squibb (BMY) says its cancer drugs Opdivo and Yervoy improved progression-free survival in a Phase 3 trial for ...
Is Bristol-Myers Squibb Company (BMY) the Best Stock to Invest In For Steady Dividends?
We recently compiled a list of the 15 Stocks to Invest in with Steady Dividends. In this article, we are going to take a look ...
Bristol-Myers Squibb Company (NYSE:BMY) is largely controlled by institutional shareholders who own 77% of the company
To get a sense of who is truly in control of Bristol-Myers Squibb Company ( NYSE:BMY ), it is important to understand the ...
Ameritas Advisory Services LLC Acquires 1,357 Shares of Bristol-Myers Squibb (NYSE:BMY)
Ameritas Advisory Services LLC increased its holdings in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 9.4% in ...
Bristol-Myers Squibb Options Trading: A Deep Dive into Market Sentiment
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and ...
bovnews3d
Bristol-Myers Squibb Co (BMY) Stock: More Strategic Than Meets the Eye
Bristol-Myers Squibb Co (BMY) stock saw a modest uptick, ending the day at $57.04 which represents a slight increase of $0.75 or 1.33% from the prior close of $56.29. The stock opened at $56.63 and ...
Insider Monkey6d
Bristol-Myers Squibb Company (BMY): A Bull Case Theory
Bristol Myers Squibb (BMY) is one such company poised for growth, as it enters a crucial data-rich period with readouts from 40 clinical trials. By 2025, five new products are expected to ...